Literature DB >> 9473270

Diagnostic nuclear medicine and risk for the fetus.

P Steenvoorde1, E K Pauwels, L K Harding, M Bourguignon, B Marière, J J Broerse.   

Abstract

The possible detrimental effects on the developing embryo subsequent to irradiation are discussed. The doses to the embryo or fetus encountered for the most common procedures in diagnostic nuclear medicine are evaluated with respect to the threshold doses and the risks per cGy. The threshold dose for fatal and non-fatal malformations or other defects is, at the lowest estimate, 5-10 cGy. The dose which the embryo or fetus receives from diagnostic nuclear medicine is below 1 cGy. For the induction of fatal cancer and for genetic defects no threshold dose is assumed. The risk for the induction of cancer is 0.03%-0.05% per cGy. The risk for the induction of genetic defects is even lower (0.024%-0.099% per cGy). It is concluded that for common diagnostic nuclear medicine procedures the risk of detrimental effects on the embryo or fetus due to radiation is negligible. On the basis of present knowledge there are no radiation safety indications for abortus provocatus as a consequence of a diagnostic nuclear medicine study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473270     DOI: 10.1007/s002590050215

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Hyperparathyroidism in pregnancy: options for localization and surgical therapy.

Authors:  Todd P W McMullen; Diana L Learoyd; David C Williams; Mark S Sywak; Stan B Sidhu; Leigh W Delbridge
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

2.  Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.

Authors:  Paolo Zanotti-Fregonara; Thomas M Koroscil; Joseph Mantil; Martin Satter
Journal:  Health Phys       Date:  2012-02       Impact factor: 1.316

3.  Sentinel lymph node biopsy in pregnant patients with breast cancer.

Authors:  Oreste Gentilini; Marta Cremonesi; Antonio Toesca; Nicola Colombo; Fedro Peccatori; Roberto Sironi; Claudia Sangalli; Nicole Rotmensz; Guido Pedroli; Giuseppe Viale; Paolo Veronesi; Viviana Galimberti; Aron Goldhirsch; Umberto Veronesi; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

4.  18F-Fludeoxyglucose Absorbed Dose Estimation in Fetus during Early Pregnancy.

Authors:  Nemat Ahmadi; Alireza Karimian; Mehdi Nasri Nasrabadi
Journal:  J Med Signals Sens       Date:  2022-05-12

5.  Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model.

Authors:  Rachel M Bartlett; Robert J Nickles; Todd E Barnhart; Bradley T Christian; James E Holden; Onofre T DeJesus
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

6.  Imaging for suspected pulmonary embolism in pregnancy-what about the fetal dose? A comprehensive review of the literature.

Authors:  Tilo Niemann; Guillaume Nicolas; Hans W Roser; Jan Müller-Brand; Georg Bongartz
Journal:  Insights Imaging       Date:  2010-10-02

Review 7.  Breast cancer in pregnancy: a literature review.

Authors:  S Deckers; F Amant
Journal:  Facts Views Vis Obgyn       Date:  2009

8.  A computer program for calculation of approximate embryo/fetus radiation dose in nuclear medicine applications.

Authors:  Tuncay Bayram; Bircan Sönmez
Journal:  Mol Imaging Radionucl Ther       Date:  2012-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.